Published in Women's Health Weekly, August 18th, 2005
"The purpose of this study was to report the results of adjuvant CPT-11 and MMC combination chemotherapy (CPT-M) for OCCA. Between 1996 and 2002, 20 patients with OCCA underwent primary debulking surgery and received 6 treatments of CPT-11 (140 mg/m2) in combination with MMC (7 mg/m2), 2 weeks apart with a space of 3-4 weeks between the 3rd and 4th treatment in adjuvant setting," scientists in Japan reported.
"Overall survival was compared with our historical control treated between 1983...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly